Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Meiqi ZhaoJianwei Zhu

Abstract

Recombinant human interleukin-15 (IL-15) is a potent cancer immunotherapeutic candidate due to its excellent immune stimulating effects. Previous work demonstrated that IL-15 appeared with short half-life in circulation system, while the complex with its receptor can prolong the half-life as well as benefit its activities in vivo. Therefore, IL-15 complex was more favorably considered for clinical development. Herein we developed IL-15·sIL-15Rα/Fc, a complex comprising of IL-15 and the extracellular region of its receptor alpha subunit which fused to Immunoglobulin G (IgG1) Fc to further prolong the half-life in plasma. Through transient gene expression in HEK293 cells, we expressed the superagonist by co-transfection of plasmids encoding IL-15 and sIL-15Rα/Fc respectively, yielding 36 mg/L of product after purification. Pharmacokinetic study demonstrated that the combination profoundly prolonged the half-life of IL-15 to 13.1 h in mice, about 18 folds longer than that of IL-15 monomer which is around 0.7 h. The bioactivity of the superagonist was characterized by CTLL-2 cells proliferation assay in vitro, showing its capability of stimulating the expansion of memory CD8+ T cells (cluster of differentiation) in mouse spleen. Us...Continue Reading

References

Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas A StoklasekLeo Lefrançois
Sep 12, 2007·Journal of Pharmaceutical Sciences·Padma Malyala, Manmohan Singh
Oct 20, 2007·The Journal of Biological Chemistry·Shaun K OlsenShigeyuki Yokoyama
Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sigrid DuboisJürgen R Müller
Oct 7, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ping YuThomas A Waldmann
Jul 16, 2015·International Journal of Cancer. Journal International Du Cancer·Dimitrios MathiosMichael Lim
May 3, 2016·Human Vaccines & Immunotherapeutics·Arun RajanJames L Gulley
May 25, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mélanie DesboisNathalie Chaput
Dec 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sinnie Sin Man NgGeorge N Pavlakis
Aug 9, 2017·Journal of Immunology Research·J M J Van den BerghE Lion
Aug 2, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Stacy J KowalskyDavid L Bartlett
Oct 6, 2018·Cell·Miguel F Sanmamed, Lieping Chen

❮ Previous
Next ❯

Citations

Dec 11, 2019·The Journal of Experimental Medicine·Thomas A WaldmannKevin C Conlon
Sep 10, 2020·Frontiers in Immunology·John A HangaskyDaniel V Santi
Jun 9, 2020·Frontiers in Immunology·Thomas A WaldmannKevin C Conlon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.